Delivery Order SPE2DB20D3303-SPE2DB25FA1NX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Promacta 25 mg tablets in quantities of 30 units, with a ceiling value of $4,418.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The Defense Logistics Agency awarded a $8,026.53 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Promacta 50 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of August 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units, with a contract ceiling value of $12,029.63 and an ultimate completion date of August 11, 2025. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,254.18 to AmerisourceBergen Drug Corp for the supply of Promacta 25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of August 11, 2025. The contract utilizes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Promacta 25 mg tablets (30-count units) valued at $4,418.06 under a firm fixed-price contract type. The award was made on July 21, 2025, with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,242.58 contract is for the supply of PROMACTA 50 MG TABLET UU 30S and has a completion date of March 18, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products from its corporate office located in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PROMACTA 50 MG TABLET UU 30S. The contract is a firm fixed-price delivery order with a ceiling value of $8,026.53 and a period of performance through July 21, 2025. The contract is not set aside and was competed openly. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROMACTA 25 MG TABLET, a pharmaceutical product, with a ceiling value of $4,418.06 and a period of performance through May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a $23,983.26 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of PROMACTA 25 MG TABLET, a specialty medication, with a period of performance through August 2024. The contract is a firm fixed-price arrangement and does not have a small business set-aside designation. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of PROMACTA 25 MG TABLET. The contract is a firm fixed-price delivery order with a ceiling value of $4,418.06 and a period of performance through July 9, 2025. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1NXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Promacta 75 mg tablets in quantities of 30 units. This firm fixed-price contract, valued at $24,059.26, represents a non-competitive set-aside award and is scheduled for completion by August 11, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves military and veteran healthcare systems through its extensive portfolio of brand-name and generic medications. The company holds a significant position within the DLA Medical Supply Chain, fulfilling delivery orders across multiple therapeutic domains through competitively awarded contracts with firm fixed pricing structures. This particular delivery order for Promacta, an immunosuppressive agent used to treat thrombocytopenia, exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare operations worldwide. The IDC vehicle under which this delivery order was issued demonstrates AmerisourceBergen's capacity to meet diverse federal medical procurement requirements efficiently and flexibly.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.1k | 7/21/25 |